Stockreport

Lenz, Lunatus announce exclusive partnership for VIZZ in Middle East [Yahoo! Finance]

LENZ Therapeutics, Inc.  (LENZ) 
PDF LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment [Read more]